All Stories

  1. Primaquine at alternative dosing schedules for preventing relapse in people withPlasmodium vivaxmalaria
  2. Elimination of lymphatic filariasis as a public health problem in Niue under PacELF, 1999–2016
  3. Investigation of Mixture Modelling Algorithms as a Tool for Determining the Statistical Likelihood of Serological Exposure to Filariasis Utilizing Historical Data from the Lymphatic Filariasis Surveillance Program in Vanuatu
  4. Preventive chemotherapy reverses covert, lymphatic‐associated tissue change in young people with lymphatic filariasis in Myanmar
  5. GEOFIL: A spatially-explicit agent-based modelling framework for predicting the long-term transmission dynamics of lymphatic filariasis in American Samoa
  6. Combining different diagnostic studies of lymphatic filariasis for risk mapping in Papua New Guinea: a predictive model from microfilaraemia and antigenaemia prevalence surveys
  7. The prevalence of lymphatic filariasis infection and disease following six rounds of mass drug administration in Mandalay Region, Myanmar
  8. Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance - American Samoa, 2016
  9. The epidemiology of tuberculosis in the rural Balimo region of Papua New Guinea
  10. Neglected and Emerging Tropical Diseases in South and Southeast Asia and Northern Australia
  11. Moderating Factors in Tissue Tonometry and Bioimpedance Spectroscopy Measures in the Lower Extremity of Healthy Young People in Australia and Myanmar
  12. Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission
  13. Expanding the Vector Control Toolbox for Malaria Elimination: A Systematic Review of the Evidence
  14. A Synthetic Population for Modelling the Dynamics of Infectious Disease Transmission in American Samoa
  15. Overview of PacELF—the Pacific Programme for the Elimination of Lymphatic Filariasis
  16. Lymphatic Filariasis Increases Tissue Compressibility and Extracellular Fluid in Lower Limbs of Asymptomatic Young People in Central Myanmar
  17. Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration
  18. Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies
  19. Prevalence and risk factors associated with lymphatic filariasis in American Samoa after mass drug administration
  20. Lymphatic Filariasis in Mainland Southeast Asia: A Systematic Review and Meta-Analysis of Prevalence and Disease Burden
  21. Surveillance efforts after mass drug administration to validate elimination of lymphatic filariasis as a public health problem in Vanuatu
  22. Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997–2006
  23. Identification and control of an isolated, but intense focus of lymphatic filariasis on Satawal Island, Federated States of Micronesia, in 2003
  24. Intrarater Reliability of Tonometry and Bioimpedance Spectroscopy to Measure Tissue Compressibility and Extracellular Fluid in the Legs of Healthy Young People in Australia and Myanmar
  25. Lymphatic Filariasis Elimination in American Samoa: Evaluation of Molecular Xenomonitoring as a Surveillance Tool in the Endgame
  26. Self-Care for Management of Secondary Lymphedema: A Systematic Review
  27. Current WHO protocols for mass drug administration in helminth control
  28. Lymphatic Filariasis in Oceania
  29. Clinical case estimates of lymphatic filariasis in an endemic district of Bangladesh after a decade of mass drug administration
  30. Determinants of Bed Net Use in Southeast Nigeria following Mass Distribution of LLINs: Implications for Social Behavior Change Interventions
  31. Surgical Treatment of Genital Manifestations of Lymphatic Filariasis: A Systematic Review
  32. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of seventh biannual meeting (March 2015)
  33. Evaluation of traps and lures for mosquito vectors and xenomonitoring of Wuchereria bancrofti infection in a high prevalence Samoan Village
  34. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of sixth biannual meeting (September 2014)
  35. Primaquine or other 8-aminoquinoline for reducingPlasmodium falciparumtransmission
  36. Seroepidemiology of melioidosis in children from a remote region of Papua New Guinea
  37. Seroprevalence and Spatial Epidemiology of Lymphatic Filariasis in American Samoa after Successful Mass Drug Administration
  38. Primaquine or other 8-aminoquinoline for reducingP. falciparumtransmission
  39. Safety of 8-aminoquinolines given to people with G6PD deficiency: protocol for systematic review of prospective studies
  40. Malaria prevalence, anemia and baseline intervention coverage prior to mass net distributions in Abia and Plateau States, Nigeria
  41. A preliminary investigation of serological tools for the detection of Onchocerca lupi infection in dogs
  42. Estimation of insecticide persistence, biological activity and mosquito resistance to PermaNet® 2 long-lasting insecticidal nets over three to 32 months of use in Ethiopia
  43. Risk factors for anemia in children under 6 years of age in Ethiopia: analysis of the data from the cross-sectional Malaria IndicatorSurvey, 2007
  44. Community-Wide Distribution of Long-Lasting Insecticidal Nets Can Halt Transmission of Lymphatic Filariasis in Southeastern Nigeria
  45. Physical durability of PermaNet 2.0 long-lasting insecticidal nets over three to 32 months of use in Ethiopia
  46. Lymphatic filariasis in Papua New Guinea: distribution at district level and impact of mass drug administration, 1980 to 2011
  47. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2013 meeting
  48. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of March 2013 meeting
  49. Primaquine for reducingPlasmodium falciparumtransmission
  50. Mosquito Feeding Assays to Determine the Infectiousness of Naturally Infected Plasmodium falciparum Gametocyte Carriers
  51. Evidence for Stopping Mass Drug Administration for Lymphatic Filariasis in Some, But Not All Local Government Areas of Plateau and Nasarawa States, Nigeria
  52. Performance of Local Light Microscopy and the ParaScreen Pan/Pf Rapid Diagnostic Test to Detect Malaria in Health Centers in Northwest Ethiopia
  53. Lymphatic filariasis in western Ethiopia with special emphasis on prevalence of Wuchereria bancrofti antigenaemia in and around onchocerciasis endemic areas
  54. Analysis of malaria surveillance data in Ethiopia: what can be learned from the Integrated Disease Surveillance and Response System?
  55. Inaugural meeting of the malaria policy advisory committee to the WHO: conclusions and recommendations
  56. Factors associated with mosquito net use by individuals in households owning nets in Ethiopia
  57. Malaria, Oromia Regional State, Ethiopia, 2001-2006
  58. Which nets are being used: factors associated with mosquito net use in Amhara, Oromia and Southern Nations, Nationalities and Peoples' Regions of Ethiopia
  59. Oral vaccines for preventing cholera
  60. Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected)
  61. Knowledge of Malaria and Its Association with Malaria-Related Behaviors—Results from the Malaria Indicator Survey, Ethiopia, 2007
  62. Oral vaccines for preventing cholera
  63. Comparison of Parascreen Pan/Pf, Paracheck Pf and light microscopy for detection of malaria among febrile patients, Northwest Ethiopia
  64. Rapid Increase in Ownership and Use of Long-Lasting Insecticidal Nets and Decrease in Prevalence of Malaria in Three Regional States of Ethiopia (2006-2007)
  65. Malaria indicator survey 2007, Ethiopia: coverage and use of major malaria prevention and control interventions
  66. Individual, household and environmental risk factors for malaria infection in Amhara, Oromia and SNNP regions of Ethiopia
  67. Primaquine for reducing transmission of Plasmodium falciparum malaria
  68. Systematic Reviews in Malaria: Global Policies Need Global Reviews
  69. Malaria prevalence and mosquito net coverage in Oromia and SNNPR regions of Ethiopia
  70. Risk factors for active trachoma in children and trichiasis in adults: a household survey in Amhara Regional State, Ethiopia
  71. Integrating an NTD with One of “The Big Three”: Combined Malaria and Trachoma Survey in Amhara Region of Ethiopia
  72. Effectiveness of malaria control during changing climate conditions in Eritrea, 1998-2003
  73. Evaluation of light microscopy and rapid diagnostic test for the detection of malaria under operational field conditions: a household survey in Ethiopia
  74. Productivity of natural and artificial containers for Aedes polynesiensis and Aedes aegypti in four American Samoan villages
  75. Wuchereria bancrofti Filariasis Control in Samoa before PacELF (Pacific Programme to Eliminate Lymphatic Filariasis)
  76. Lymphatic filariasis elimination in the Pacific: PacELF replicating Japanese success
  77. Vaccines for preventing malaria (blood-stage)
  78. Vaccines for preventing malaria (pre-erythrocytic)
  79. Vaccines for preventing malaria (SPf66)
  80. The Benefits of Artemisinin Combination Therapy for Malaria Extend Beyond the Individual Patient
  81. Malaria, Babesiosis, Theileriosis and Related Diseases
  82. Impregnated Nets Cannot Fully Substitute for DDT: Field Effectiveness of Malaria Prevention in Solomon Islands
  83. Vaccines for preventing malaria
  84. Vaccines for preventing malaria
  85. Prospective study of enteroviral infections and development of beta-cell autoimmunity
  86. Vaccines for preventing cholera
  87. Malaria, Babesiosis, Theileriosis and Related Diseases
  88. Lack of association between early childhood immunizations and beta-cell autoimmunity
  89. Pathogenesis, prediction and trials for the prevention of insulin-dependent (type 1) diabetes mellitus1Abbreviations: s.c., subcutaneous; i.p., intraperitoneal; i.v., intravenous; IFA, incomplete Freund's adjuvant; DTP, diphtheria-tetanus-pertussis; LC...
  90. Prevention of Type 1 Diabetes from Laboratory to Public Health
  91. The SPf66 Malaria Vaccine: What is the Evidence for Efficacy?
  92. Comparison of the cost-effectiveness of vaccines and insecticide impregnation of mosquito nets for the prevention of malaria
  93. Vaccines for preventing tick-borne encephalitis
  94. Vaccines for preventing anthrax
  95. Vaccines for preventing anthrax
  96. The role of enteroviral infections in the development of IDDM: limitations of current approaches
  97. The Role of Enteroviral Infections in the Development of IDDM: Limitations of Current Approaches
  98. Mortality From Intentional and Unintentional Injury Among Infants of Young Mothers in Colorado, 1986 to 1992
  99. Human Malaria Transmission: Reconciling Field and Laboratory Data
  100. Malaria Vaccines
  101. Antibody responses to Plasmodium falciparum gametocyte antigens during and after malaria attacks in schoolchildren from Madang, Papua New Guinea
  102. Refractoriness of erythrocytes infected with Plasmodium falciparum gametocytes to lysis by sorbitol
  103. Properties of epitopes of Pfs 48/45, a target of transmission blocking monoclonal antibodies, on gametes of different isolates of Plasmodium falciparum
  104. The primary antibody response of malaria patients to Plasmodium falciparum sexual stage antigens which are potential transmission blocking vaccine candidates
  105. The prevalence of naturally acquired multiple infections of Wuchereria bancrofti and human malarias in anophelines
  106. Estimation of Anopheline Survival Rate, Vectorial Capacity and Mosquito Infection Probability from Malaria Vector Infection Rates in Villages Near Madang, Papua New Guinea
  107. A Cyclical Feeding Model for Pathogen Transmission and Its Application to Determine Vectorial Capacity from Vector Infection Rates
  108. Sequence coding for a sexual stage specific protein of Plasmodium falciparum
  109. Sequence coding for a sexual stage specific protein ofPlasmodium falciparum
  110. Plasmodium falciparum: An abundant stage-specific protein expressed during early gametocyte development
  111. Human host selection by anophelines: no evidence for preferential selection of malaria or microfilariae-infected individuals in a hyperendemic area
  112. Restricted or absent immune responses in human populations to Plasmodium falciparum gamete antigens that are targets of malaria transmission-blocking antibodies
  113. Mixed Blood Feeding by the Malaria Vectors in the Anopheles punctulatus Complex (Diptera: Culicidae)
  114. Evidence for a ‘memorized’ home range in Anopheles farauti females from Papua New Guinea
  115. Measurement of malarial infectivity of human populations to mosquitoes in the Madang area, Papua New Guinea
  116. Antibodies to Plasmodium falciparum gamete surface antigens in Papua New Guinea sera
  117. Immunity to Sexual Stages of Malaria Parasites
  118. The effect of permethrin-impregnated bednets on a population of Anopheles farauti in coastal Papua New Guinea
  119. Field Evaluation of Enzyme-linked Immunosorbent Assays for Plasmodium falciparum and Plasmodium vivax Sporozoites in Mosquitoes (Diptera: Culicidae) from Papua New Guinea1
  120. Capture-recapture studies with mosquitoes of the group of Anopheles punctulatus Dönitz (Diptera: Culicidae) from Papua New Guinea
  121. Target Antigens in Malaria Transmission Blocking Immunity
  122. Mechanism of pyrimethamine resistance in recent isolates of Plasmodium falciparum.
  123. Plasmodium falciparum: Effect of time in continuous culture on binding to human endothelial cells and amelanotic melanoma cells
  124. Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum
  125. Susceptibility ofAnopheles gambiaetoPlasmodium yoelii nigeriensisandPlasmodium falciparum
  126. A Cage Replacement Experiment Involving Introduction of Genes for Refractoriness to Plasmodium Yoelii Nigeriensis into a Population of Anopheles Gambiae (Diptera: Culicidae)
  127. Studies on the use of a membrane feeding technique for infecting Anopheles gambiae with Plasmodium falciparum
  128. Immunity to Sexual Stages of Malaria Parasites